Turning gamma delta (γδ) T cells and natural killer (NK) cells into “off-the-shelf” immunotherapeutics for various cancers. Note: The image shows iPSC-derived NK cells and the video shows iPSC-derived γδ T cells killing colorectal cancer cells.
